Hypertension and sexual dysfunction

South African Family Practice

Volumn 54, Issue 2, 2012, Pages 117-118

  Ker, J A ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antihypertensive medication; Hypertension; Phosphodiesterase 5 inhibitors; Sexual dysfunction

Indexed keywords

ANTIHYPERTENSIVE AGENT; PHOSPHODIESTERASE V INHIBITOR;

ALCOHOL CONSUMPTION; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERTENSION; MEDICATION COMPLIANCE; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SMOKING; TREATMENT OUTCOME;

EID: 84904250245     PISSN: 1726426X     EISSN: None     Source Type: Journal    
DOI: 10.1080/20786204.2012.10874189     Document Type: Review

References (5)

1. Llisterri JL, Lozano Vidal JV, Aznar Vicente J. Sexual dysfunction in hypertensive patients treated with Losartan. Am J Med Sci. 2001; 321(5): 336-341.
2. Manolis A, Doumas M. Sexual dysfunction: the "prima ballerina" of hypertensionrelated quality-of-life complications. J Hypertens. 2008; 26(11): 2074-2084.
3. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003; 139(3): 161-168.
4. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994; 151(1): 54-61.
5. Laumann EO, Paik A, Rosen RC, et al. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999; 281(6): 537-544.